Oncogene - Table of Contents alert Volume 35 Issue 45

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 35, Issue 45 (November 2016) In this issue Review Original Articles Letter to the Editor Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top A comprehensive profile of recurrent glioblastoma B Campos, L R Olsen, T Urup and H S Poulsen Oncogene 2016 35: 5819-5825; advance online publication, April 4, 2016; 10.1038/onc.2016.85 Abstract | Full Text Original Articles Top SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer OPEN Z Zhou, M Wang, J Li, M Xiao, Y E Chin, J Cheng, E T H Yeh, J Yang and J Yi Oncogene 2016 35: 5826-5838; advance online publication, May 16, 2016; 10.1038/onc.2016.124 Abstract | Full Text Intestinal knockout of Nedd4 enhances growth of Apcmin tumors C Lu, C Thoeni, A Connor, H Kawabe, S Gallinger and D Rotin Oncogene 2016 35: 5839-5849; advance online publication, April 18, 2016; 10.1038/onc.2016.125 Abstract | Full Text Breast cancer antiestrogen resistance 3–p130Cas interactions promote adhesion disassembly and invasion in breast cancer cells A M Cross, A L Wilson, M S Guerrero, K S Thomas, A I Bachir, K E Kubow, A R Horwitz and A H Bouton Oncogene 2016 35: 5850-5859; advance online publication, April 25, 2016; 10.1038/onc.2016.123 Abstract | Full Text NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK–eIF2α–ATF4 signalling in breast cancer OPEN A Gupta, M M Hossain, N Miller, M Kerin, G Callagy and S Gupta Oncogene 2016 35: 5860-5871; advance online publication, April 25, 2016; 10.1038/onc.2016.121 Abstract | Full Text Targeting TYRO3 inhibits epithelial–mesenchymal transition and increases drug sensitivity in colon cancer C-W Chien, P-C Hou, H-C Wu, Y-L Chang, S-C Lin, S-C Lin, B-W Lin, J-C Lee, Y-J Chang, H S Sun and S-J Tsai Oncogene 2016 35: 5872-5881; advance online publication, May 2, 2016; 10.1038/onc.2016.120 Abstract | Full Text Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival S Joshi, S Kumar, M P Ponnusamy and S K Batra Oncogene 2016 35: 5882-5892; advance online publication, April 25, 2016; 10.1038/onc.2016.119 Abstract | Full Text α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer H-T An, S Yoo and J Ko Oncogene 2016 35: 5893-5904; advance online publication, April 11, 2016; 10.1038/onc.2016.117 Abstract | Full Text MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents M Y Shah, E Martinez-Garcia, J M Phillip, A B Chambliss, R Popovic, T Ezponda, E C Small, C Will, M P Phillip, P Neri, N J Bahlis, D Wirtz and J D Licht Oncogene 2016 35: 5905-5915; advance online publication, April 25, 2016; 10.1038/onc.2016.116 Abstract | Full Text A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy C Zhao, X Chen, D Zang, X Lan, S Liao, C Yang, P Zhang, J Wu, X Li, N Liu, Y Liao, H Huang, X Shi, L Jiang, X Liu, Z He, Q P Dou, X Wang and J Liu Oncogene 2016 35: 5916-5927; advance online publication, April 18, 2016; 10.1038/onc.2016.114 Abstract | Full Text Letter to the Editor Top Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis A Oweida and B Abdulkarim Oncogene 2016 35: 5928-5929; advance online publication, April 25, 2016; 10.1038/onc.2016.130 Full Text Corrigendum Top HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas J M Hoyos, A Ferraro, S Sacchetti, S Keller, I De Martino, E Borbone, P Pallante, M Fedele, D Montanaro, F Esposito, P Cserjesi, L Chiariotti, G Troncone and A Fusco Oncogene 2016 35: 5930; advance online publication, June 27, 2016; 10.1038/onc.2016.137 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.